UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review

Archives of gynecology and obstetrics, 2021-02, Vol.303 (2), p.337-345

2021

Volltextzugriff (PDF)

Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis

Thrombosis journal, 2021-05, Vol.19 (1), p.32-32, Article 32

2021

Volltextzugriff (PDF)

The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients

Scientific reports, 2019-02, Vol.9 (1), p.1691-1691, Article 1691

2019

Volltextzugriff (PDF)

Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism

Nature genetics, 2015-02, Vol.47 (2), p.158-163

2015

Volltextzugriff (PDF)

Identification of a Novel Model for Predicting the Prognosis and Immune Response Based on Genes Related to Cuproptosis and Ferroptosis in Ovarian Cancer

Cancers, 2023-01, Vol.15 (3), p.579

2023

Volltextzugriff (PDF)

Editorial: Towards better and personalized management of ovarian cancer in China

BJOG : an international journal of obstetrics and gynaecology, 2022-11, Vol.129 (S2), p.3-4

Gao, Qinglei

2022

Volltextzugriff (PDF)

Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells

Autophagy, 2015-10, Vol.11 (10), p.1849-1863

2015

Volltextzugriff (PDF)

Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis

Journal of ovarian research, 2023-07, Vol.16 (1), p.136-136, Article 136

2023

Volltextzugriff (PDF)

A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients

BMC cancer, 2019-11, Vol.19 (1), p.1061-1061, Article 1061

2019

Volltextzugriff (PDF)

Expression of PAWR predicts prognosis of ovarian cancer

Cancer cell international, 2020-12, Vol.20 (1), p.598-598, Article 598

2020

Volltextzugriff (PDF)

Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles

Carcinogenesis (New York), 2019-10, Vol.40 (10), p.1220-1228

2019

Volltextzugriff (PDF)

Effectiveness and Safety of Niraparib as Neoadjuvant Therapy in Advanced Ovarian Cancer With Homologous Recombination Deficiency (NANT): Study Protocol for a Prospective, Multicenter, Exploratory, Phase 2, Single-Arm Study

Frontiers in oncology, 2022-03, Vol.12, p.852772-852772

2022

Volltextzugriff (PDF)

Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming

Cell death & disease, 2017-06, Vol.8 (6), p.e2870-e2870

2017

Volltextzugriff (PDF)

Cyclin-Dependent Kinase Inhibitors Function as Potential Immune Regulators via Inducing Pyroptosis in Triple Negative Breast Cancer

Frontiers in oncology, 2022-06, Vol.12, p.820696-820696

2022

Volltextzugriff (PDF)

Decreased DHRS2 expression is associated with HDACi resistance and poor prognosis in ovarian cancer

Epigenetics, 2020-02, Vol.15 (1-2), p.122-133

2020

Volltextzugriff (PDF)

Targeting INHBA in Ovarian Cancer Cells Suppresses Cancer Xenograft Growth by Attenuating Stromal Fibroblast Activation

Disease markers, 2019, Vol.2019, p.7275289-13

2019

Volltextzugriff (PDF)

Correction to: The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma

Journal of cancer research and clinical oncology, 2020-05, Vol.146 (5), p.1377-1377

2020

Volltextzugriff (PDF)

Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis

Anti-cancer agents in medicinal chemistry, 2017-07, Vol.17 (8), p.1093

2017

Volltextzugriff (PDF)

Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer

Journal of hematology and oncology, 2017-01, Vol.10 (1), p.29-29, Article 29

2017

Volltextzugriff (PDF)

FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer

Journal of experimental & clinical cancer research, 2018-02, Vol.37 (1), p.32-32, Article 32

2018

Volltextzugriff (PDF)

Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study

Journal of ovarian research, 2023-06, Vol.16 (1), p.121-121, Article 121

2023

Volltextzugriff (PDF)

Evaluation of the prognostic value of lymphadenectomy for low-grade serous ovarian cancer: A case-control multicenter retrospective study

Translational oncology, 2022-09, Vol.23, p.101476-101476, Article 101476

2022

Volltextzugriff (PDF)

Co-targeting EGFR and Autophagy Impairs Ovarian Cancer Cell Survival during Detachment from the ECM

Current cancer drug targets, 2015-05, Vol.15 (3), p.215

2015

Volltextzugriff (PDF)

An effective vaginal gel to deliver CRISPR/Cas9 system encapsulated in poly (β-amino ester) nanoparticles for vaginal gene therapy

EBioMedicine, 2020-08, Vol.58, p.102897-102897, Article 102897

2020

Volltextzugriff (PDF)

Correction to: FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer

Journal of experimental & clinical cancer research, 2019-10, Vol.38 (1), p.415-415, Article 415

2019

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

ThemaTumors

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Englisch
(82)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review

Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis

The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients

Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism

Identification of a Novel Model for Predicting the Prognosis and Immune Response Based on Genes Related to Cuproptosis and Ferroptosis in Ovarian Cancer

Editorial: Towards better and personalized management of ovarian cancer in China

Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells

Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis

A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients

Expression of PAWR predicts prognosis of ovarian cancer

Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles

Effectiveness and Safety of Niraparib as Neoadjuvant Therapy in Advanced Ovarian Cancer With Homologous Recombination Deficiency (NANT): Study Protocol for a Prospective, Multicenter, Exploratory, Phase 2, Single-Arm Study

Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming

Cyclin-Dependent Kinase Inhibitors Function as Potential Immune Regulators via Inducing Pyroptosis in Triple Negative Breast Cancer

Decreased DHRS2 expression is associated with HDACi resistance and poor prognosis in ovarian cancer

Targeting INHBA in Ovarian Cancer Cells Suppresses Cancer Xenograft Growth by Attenuating Stromal Fibroblast Activation

Correction to: The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma

Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis

Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer

FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer

Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study

Evaluation of the prognostic value of lymphadenectomy for low-grade serous ovarian cancer: A case-control multicenter retrospective study

Co-targeting EGFR and Autophagy Impairs Ovarian Cancer Cell Survival during Detachment from the ECM

An effective vaginal gel to deliver CRISPR/Cas9 system encapsulated in poly (β-amino ester) nanoparticles for vaginal gene therapy

Correction to: FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer

Aktive Filter

Suchergebnisse filtern